The role of nuclear medicine in the evaluation of complex regional pain syndrome type I

Clinical Nuclear Medicine

Volumn 30, Issue 6, 2005, Pages 400-407

  Intenzo, Charles M ^a   Kim, Sung M ^a   Capuzzi, David M ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Bone scintigraphy; Complex regional pain syndrome; Reflex sympathetic dystrophy

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; CALCIUM CHANNEL BLOCKING AGENT; CYSTEINE ETHYL ESTER TC 99M; MEDRONATE TECHNETIUM TC 99M; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

BONE SCINTISCANNING; CLINICAL FEATURE; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; EVALUATION; HUMAN; HYDROTHERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC BLOCKING; TRANSCUTANEOUS NERVE STIMULATION;

BONE DISEASES; BRAIN DISEASES; HUMANS; NUCLEAR MEDICINE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; REFLEX SYMPATHETIC DYSTROPHY; SEVERITY OF ILLNESS INDEX;

EID: 19544388407     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000162605.14734.11     Document Type: Review

References (42)

1. Sandroni P, Benrud-Larson LM, et al. Complex regional pain syndrome type I; incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103:199-207.
2. Oerlemans HM, Oostendorp RA, et al. Signs and symptoms in complex regional pain syndrome type I/reflex sympathetic dystrophy: judgment of physician vs objective measurement. Clin J Pain. 1999;15:224-232.
3. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127-133.
4. Maleki J, LeBel AA, Bennett GJ, et al. Patterns of spread in complex regional pain syndrome type I (reflex sympathetic dystrophy). Pain. 2000;88:259-266.
5. Harden RN, Breuhl S, Galer BS, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain. 1999;83:211-219.
6. Evans JA. Reflex sympathetic dystrophy. Surg Clin North Am, 1946;26:780-790.
7. Blumberg H, Hoffman V, Mohadjes M, et al. Sympathetic nervous system and pain: a clinical reappraisal. Behav Brain Sci. 1997;20:426-434.
8. Mosker A, Boersma FP, Schijgrand HW, et al. Treatment of posttraumatic sympathetic dystrophy (Sudeck's atrophy) with guanethidine and ketanserin. Pain Clinic. 1985;1:171-176.
9. Baron R, Levine JD, Field HL. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? Muscle Nerve. 1999;22:678-695.
10. Zuniga RE, Perera S, Abram SE. Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome. Reg Anesth Pain Med. 2002;27:90-93.
11. Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 828 patients. Lancet. 1993;342:1012-1016.
12. Birkelein F, Reidl B, Neundorfer B, et al. Sympathetic vasoconstrictor reflex pattern in patients with complex regional pain syndrome. Pain. 1998;75:93-100.
13. van de Beek WJ, Schwartzman RJ, van Nes SI, et al. Diagnostic criteria used in studies of reflex sympathetic dystrophy. Neurology. 2002;38:522-526.
14. Kurvers HA. Reflex sympathetic dystrophy: facts and hypothesis. Vasc Med. 1998;3:207-214.
15. Pham T, Lafforgue P. Reflex sympathetic dystrophy and neuromediators. Joint Bone Spine. 2003;70:12-17.
16. Turner-Stokes L. Reflex sympathetic dystrophy - a complex regional pain syndrome. Disabil Rehabil. 2002;24:939-947.
17. Drummond PHD, Finch PM, Smythe GA. Reflex sympathetic dystrophy: the significance of differing plasma catecholamine concentrations in affected and unaffected limbs. Brain. 1991;114:2025-2036.
18. Goldstein DS, Tack C, Li ST. Sympathetic innervation and function in reflex sympathetic dystrophy. Ann Neurol. 2000;48:49-59.
19. Teasdall RD, Paterson-Smith B, Koman LA. Complex regional pain syndrome (reflex sympathetic dystrophy). Clin Sports Med. 2004;23:145-155.
20. Schwartzman RJ, Pomperow A. Reflex sympathetic dystrophy. Curr Rheumatol Rep. 2002;4:165-169.
21. Law PA, Amadio PC, Wilson PR, et al. Laboratory findings in reflex sympathetic dystrophy: a preliminary report. Clin J Pain. 1994;10:235-239.
22. Smith DL, Campbell SM. Reflex sympathetic dystrophy syndrome: diagnosis and management. West J Med. 1987;147:342-352.
23. Todorovic-Tirnanic M, Obradovic V, Han R, et al. Diagnostic approach to reflex sympathetic dystrophy after fracture: radiography or bone scintigraphy? Eur J Nucl Med. 1999;22:1187-1193.
24. Cuartero-Plaza A, Martinez-Miralles E, Benito-Ruiz P, et al. Abnormal bone scintigraphy and silent radiography in localized reflex sympathetic dystrophy syndrome. Eur J Nucl Med. 1992;19:330-333.
25. Holder LE, Cole LA, Myerson MS. Reflex sympathetic dystrophy in the foot: clinical and scintigraphic criteria. Radiology. 1992;184:531-535.
26. Intenzo C, Kim S, Millin J, et al. Scintigraphic patterns of the reflex sympathetic dystrophy syndrome of the lower extremities. Clin Nucl Med. 1989;14:657-661.
27. Zyluk A, Berkenfeld B. Quantitative evaluation of three-phase bone scintigraphy before and after the treatment of posttraumatic reflex sympathetic dystrophy. Nucl Med Commun. 1999;20:327-333.
28. Weiss L, Alfano A, Bardfeld P, et al. Prognostic value of triple-phase bone scanning for reflex sympathetic dystrophy in hemiplegia. Arch Phys Med Rehabil. 1993;74:716-719.
29. Apkarian AV, Stea RA, Manglos SH, et al. Persistent pain inhibits contralateral somatosensory cortical activity in humans. Neurosci Lett. 1992;140:141-147.
30. Cighill RC, Talbot JD, Evans AC, et al. Distributed processing of pain and vibration by the human brain. J Neurosci. 1994;14:4095-4108.
31. Casey KL, Minoshima S, Berger KL, et al. Positron emission tomography analysis of cerebral structures activated specifically by repetitive noxious stimuli. J Neurophysiol. 1994;2:802-807.
32. Hsieh J, Belfrage M, Stine-Elander S, et al. Central representation of chronic ongoing neuropathic pain studies by positron emission tomography. Pain. 1995;63:225-236.
33. Cesaro P, Mann MW, Moretti J, et al. Central pain and thalamic hyperactivity: a SPECT study. Pain. 1991;47:324-336.
34. Garcia-Larrea L, Peyron R, Merteas P, et al. Positron emission tomography during motor cortex stimulation for pain control. Stereotact Funct Neurosurg. 1997;68:141-148.
35. Fukui S, Shigemori S, Nosaka S. Changes in regional cerebral blood flow in the thalamus after electroconvulsive therapy for patients with complex regional pain syndrome type I (preliminary case series). Reg Anesth Pain Med. 2002;27:529-532.
36. Cortel B, Flipo RM, Coquerelle P, et al. Treatment of severe recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation biphosphonate pamidronate. Clin Rheumatol. 1997;16:51-56.
37. Kubalek I, Fain O, Paries J, et al. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology. 2001;40:1394-1397.
38. Carter ML. Spinal cord stimulation in chronic pain: a review of the evidence. Anesth Intensive Care. 2004;1:11-21.
39. Heck, L. Recognition of atypical reflex sympathetic dystrophy. Clin Nucl Med. 1987;12:925-928.
40. Wasner G, Schattschneider J, Heckmann K, et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic values. Brain. 2001;124:587-599.
41. Holder LE. Clinical radionuclide bone imaging. Radiology. 1990;176:607-614.
42. Fukumoto M, Ushida T, Zinchak VS, et al. Contralateral thalamic perfusion in patients with reflex sympathetic dystrophy syndrome. Lancet. 1999;354:1971.